Recently, I’ve written a couple of posts about the use of microfluidics-based devices in neurobiology research.
Today, Technology Review has an article about the use of this technology in developing drug treatments for Parkinson’s disease:
Mehmet Fatih Yanik, assistant professor of electrical engineering and computer science at MIT, is developing microfluidic devices that could greatly facilitate experiments, including whole-genome screening and drug testing, on…C. elegans.
In one type of experiment possible with the new microfluidic device, worms on the chip can be treated with compounds for high-throughput drug screens. Such automated drug screens, which are currently performed on single cells, have not been practical in whole, live animals in the past.